Live · 18 Sep 2026 SPX 7,637.76 +1.14% NDX 29,446.98 +1.73% VIX 15.44 -12.82% GOLD 4,405.80 +0.14% CL 101.02 -0.87% BTC 77,436.19 +0.00%
NAS100 29,447 +1.73% S&P 7,638 +1.14% GOLD $4,406 +0.14% BTC $77,436 VIX 15.44 −12.82% live tape · as of 11:00 UTC
The Screen · Technology · Software - Application

Chime Financial, Inc.

CHYM · Nasdaq · USD · Market cap $12.5B · 1,519 employees

Chime Financial, Inc., a financial technology company, provides digital consumer banking and payment solutions in the United States and internationally.

FAIL · Does not pass the screen
33.00 USD

At the last full screen
2026-09-11

Screened 2026-09-11 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

Chime Financial, Inc. holds its Markdown at $33.00. The statistical read favours the sellers, held for 25 days.

As held on the ledger · 2026-09-11
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 25 days
Price at the screen$33.00
Valuation6.15 trailing · 20.50 forward price to earnings
Values screenFAIL · score 70.0
The Workings

Five Screens, Shown in Full

Does not pass. Business activity: conventional financial services

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean No prohibited business activity identified Fail
Debt load 6.85% Below 33% Interest-bearing debt is just 6.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 29.92% Below 33% Cash held in interest-bearing accounts and securities is 29.9% of assets, under the one-third limit. Pass
Receivables 36.86% Below 49% Money owed to the company is 36.9% of assets, under the 49% limit. Pass
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

31.40Conservative39.93Base case52.33Growth case 33.00Price

Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 21.0% margin of safety to the base estimate.

The Street's Range
22.00Street low 38.00Street average 50.00Street high 33.00Price

Third-party analyst targets: 21 covering, consensus Buy. The average target sits +15% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$52.7$33.4$14.2TODAY6m agoPROJECTIONStreet high$50.00 +197%Our fair value$39.93 +138%Street avg$38.00 +126%Conservative$31.40 +87%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Chime chases banking users while bleeding cash

Picture a young worker in Ohio using Chime to dodge overdraft fees and get paid two days early. The app has built real usage, yet the business still loses 42 pence on every pound of revenue and posts an 80% negative return on equity. Our screen gives it a clean ethical pass, but the opportunity rating stays at none because the path to sustained profit remains unclear despite 25% revenue growth and a forward multiple of 13.9 times.

Analysts like the story and set a 30 dollar median target against the current 22.33 dollar price, and our own fair value sits higher at 35.41. That margin looks attractive on paper. We still pass because unknown competitive strength and persistent losses outweigh the headline numbers.

High growth in consumer fintech often masks thin margins and execution risk until scale arrives. Currency moves or a slowdown in user adds could widen the losses further. The ethical clearance is welcome, yet it does not turn unprofitable operations into an investable case right now. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E20.5xfairly priced for its growth rate
Trailing P/E6.1xvery cheap relative to earnings
EPS, trailing5.37
EPS, forward1.61
Revenue growth+26.8%strong top-line growth
Profit margin-0.7%currently unprofitable
Return on equity-1.3%not currently earning a positive return on equity
FCF yield3.50%
Debt to equity0.13minimal debt: a conservative balance sheet
Current ratio4.62comfortably covers its short-term bills
Short interest, float0.07%
52-week range15.88 - 35.55
Market cap$12.5B
Employees1,519

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CHYM trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-08-25 Markup · changed $31.25 +39.9% Entry 5

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 39.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (18 analysts) rates it buy, with a mean price target of $31.

2026-07-24 Markdown $22.33 +33.7% Entry 4

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 33.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (18 analysts) rates it buy, with a mean price target of $31.

2026-07-18 Markdown $16.70 +0.0% Entry 3

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Our forward projection puts the odds of a 10% gain over the next month near 18%. The street (18 analysts) rates it buy, with a mean price target of $31.

2026-07-03 Markdown $16.70 +0.0% Entry 2

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Markdown $16.70 Entry 1

The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in CHYM's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · CHYM
DateInsiderTitleTypeSharesValue
2026-09-10 Carolan Shawn T Dir S - Sale 579,313 $19,194,540
2026-09-10 Feuille James Dir S - Sale 351,890 $11,611,184
2026-09-11 Marshall Cynthia Dir S - Sale 20,000 $661,866

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $18.23 -7.8% · $922 -7.8%
2 months $19.61 -14.3% · $857 -14.3%
3 months $21.62 -22.3% · $778 -22.3%
6 months $27.49 -38.9% · $612 -38.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CHYM does next, these words stay.

Chime Financial, Inc. · CHYM · Markdown · $33.00
Recorded 2026-09-11 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.